New antibody targets cancer-causing HER2 mutations

For some proteins, a single mutation, or change in its DNA instructions, is all it takes to tip the balance between functioning normally and causing cancer.

DUOS Raises $10M to Empower Older Adults to Live Independently

What You Should Know: DUOS, a digital health company focused on empowering older adults to live independently, announced today an additional $10M in funding led

June 22, 2023

Deka Biosciences secures $20m to advance product pipeline

The company will use the funding proceeds to progress its pipeline and the production of drug products. Credit: Matveev Aleksandr/Shutterstock.com. Deka Biosciences has secured funding of

September 29, 2023

Proteomic study pinpoints potential biomarkers for long-COVID diagnosis and persistent health impacts

A two-year longitudinal study highlights proteomic changes in long-COVID patients, revealing potential biomarkers for diagnosis and shedding light on the persistent physiological challenges faced by

November 7, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.